 , 0.46; 95% CI, 0.180.99).134
There is considerable evidence supporting dual antiplatelet therapy in secondary stroke prevention. In the Clopidogrel in High Risk Patients with Acute Nondisabling
Cerebrovascular events (CHANCE) trial, patients were randomized to aspirin Ã¾ clopidogrel or aspirin alone within
24 hours of experiencing a TIA or minor stroke.